SEC Form 4 · accession 0001209191-15-049484
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha J Demski
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 2:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 2,000 | $1.53 | A | 2,000 | D | |
| Common StockF2 | Jun 1, 2015 | S | 2,000 | $41.5821 | D | 0 | D | |
| Common Stock | holding | — | — | — | 14,788 | I | By the Martha J. Demski Trust u/a 10/01/94 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.53 | Jun 1, 2015 | M | 2,000 | D | — | Jun 25, 2018 | Common Stock | 2,000 | 9,126 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- F2The range of sale prices received is $41.38 to $41.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price.
- F3Immediately exercisable.